A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Statum Systems Unveils Way to Replace Hospital Pagers

September 1, 2020

Statum Systems, a healthcare IT startup, today announced StatumHEALTH, a HIPAA-compliant medical communication and collaboration platform that securely connects caregivers with each other and with hospital systems and data.

“Statum Systems was founded to solve a critical problem plaguing healthcare today – inefficient and unreliable communications among care teams,” said Dr. Arman Serebrakian, a surgery resident and company co-founder.

StatumHEALTH is the only solution that allows users to receive critical messages on smartphones in locations without WiFi or cell coverage, enabling medical professionals to stop carrying pagers or other specialty communication devices.

“Caregivers are forced to constantly toggle between pagers, smartphone apps, hospital systems and telephones to access EHR and collaborate with colleagues, making it difficult to communicate competently,” added Dr. Serebrakian. “And that’s why we developed this innovation.”

StatumHEALTH’s patent-pending technology streamlines collaboration workflows and increases caseload efficiency with fast access to medical systems (like EHR) and the ability to quickly reach the right person by voice, text or video – all from a regular smartphone.

StatumHEALTH patient care sessions ensure that medical teams can conduct secure, confidential HIPAA-compliant dialogues. Built-in intelligence alerts caregivers of relevant dialogues and provides additional patient-related information upon request. StatumHEALTH collects unique communication and productivity data, enabling improved performance and quality monitoring and predictive analytics.

“Dramatically improving the way medical professionals collaborate is critical for delivering quality care,” says Fred Lizza, Statum Systems CEO. “Patients realize better health outcomes, as caregivers work with fewer communication errors and delays, and medical centers improve their financial stance. From healthcare crises to everyday operations, it’s critical for our essential caregivers to have access to the right tools.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy